Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Longboard Pharmaceuticals To Present Data On Bexicaserin At The 15th Annual European Epilepsy Congress In Rome, Highlighting Safety, Efficacy, And Therapeutic Potential For Developmental And Epileptic Encephalopathies; Phase 3 Program Set To Begin This Year

Author: Benzinga Newsdesk | August 26, 2024 04:03pm

Posted In: LBPH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist